Cutia Therapeutics (HKG:2487)
Hong Kong · Delayed Price · Currency is HKD 1.950
-0.050 (-2.50%)
Aug 27, 2026, 4:08 PM HKT
Cutia Therapeutics Stock Forecast
HKG-2487's stock price has decreased by -80.1% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 2 analysts polled by S&P Global, Cutia Therapeutics stock has a consensus rating of "Buy" and an average price target of $11.43. The average 1-year stock price forecast is 486.15% higher than the current stock price, while the lowest is $7.66 (+292.82%) and the highest is $15.19 (+678.97%).
Price Target: $11.43 (+486.15%)
Analyst Consensus: Buy
Price Target
Chart* Price targets were last updated on Mar 31, 2026.
Analyst Ratings
The average analyst rating for Cutia Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Sep '25 | Dec '25 | Jan '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst CICC No rating | CICC | Buy Maintains $7.45 | Buy | Maintains | $7.45 | +282.05% | Mar 31, 2026 |
Financial Forecast
Revenue This Year
645.87M
from 336.15M
Increased by 92.14%
Revenue Next Year
1.18B
from 645.87M
Increased by 82.67%
EPS This Year
-0.46
from -1.03
EPS Next Year
0.13
from -0.46
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.